Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2015

01.08.2015 | Maternal-Fetal Medicine

Effects of vitamin C, vitamin E, and molecular hydrogen on the placental function in trophoblast cells

verfasst von: Zhong Guan, Huai-fang Li, Li-li Guo, Xiang Yang

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Aim

This study aimed to investigate the effects of three different antioxidants, namely vitamin C, vitamin E, and molecular hydrogen, on cytotrophoblasts in vitro.

Methods

Two trophoblast cell lines, JAR and JEG-3, were exposed to different concentrations of vitamin C (0, 25, 50, 100, 500, 1,000, 5,000 μmol/L), vitamin E (0, 25, 50, 100, 500, 1,000, 5,000 μmol/L), and molecular hydrogen (0, 25, 50, 100, 500 μmol/L) for 48 h. The cell viability was detected using the MTS assay. The secretion of human chorionic gonadotropin (hCG) and the tumor necrosis factor-α (TNF-α) were assessed and the expression of TNF-α mRNA was observed by real-time RT-PCR.

Results

Cell viability was significantly suppressed by 500 μmol/L vitamins C and E (P < 0.05), but not by 500 μmol/L molecular hydrogen (P > 0.05). The expression of TNF-α was increased by 100 μmol/L vitamin C and 50 μmol/L vitamins E, separately or combined (P < 0.05), but not by molecular hydrogen (0–500 μmol/L), as validated by real-time RT-PCR. But the secretion of hCG was both inhibited by 50–500 μmol/L molecular hydrogen and high levels of vitamin C and E, separately or combined.

Conclusion

High levels of antioxidant vitamins C and E may have significant detrimental effects on placental function, as reflected by decreased cell viability and secretion of hCG; and placental immunity, as reflected by increased production of TNF-a. Meanwhile hydrogen showed no such effects on cell proliferation and TNF-α expression, but it could affect the level of hCG, indicating hydrogen as a potential candidate of antioxidant in the management of preeclampsia (PE) should be further studied.
Literatur
2.
Zurück zum Zitat Yang X et al (2012) Analysis of the original causes of placental oxidative stress in normal pregnancy and pre-eclampsia: a hypothesis. J Matern Fetal Neonatal Med 25(7):884–888PubMedCrossRef Yang X et al (2012) Analysis of the original causes of placental oxidative stress in normal pregnancy and pre-eclampsia: a hypothesis. J Matern Fetal Neonatal Med 25(7):884–888PubMedCrossRef
3.
Zurück zum Zitat Roberts JM, Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354(9181):788–789PubMedCrossRef Roberts JM, Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354(9181):788–789PubMedCrossRef
4.
5.
Zurück zum Zitat Serdar Z et al (2003) Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 268(1):19–25PubMed Serdar Z et al (2003) Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 268(1):19–25PubMed
6.
Zurück zum Zitat Suhail M, Faizul Suhail M, Khan H (2008) Role of vitamins C and E in regulating antioxidant and pro-oxidant markers in preeclampsia. J Clin Biochem Nutr 43(3):210–220PubMedCentralPubMedCrossRef Suhail M, Faizul Suhail M, Khan H (2008) Role of vitamins C and E in regulating antioxidant and pro-oxidant markers in preeclampsia. J Clin Biochem Nutr 43(3):210–220PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Spinnato JA 2nd et al (2007) Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 110(6):1311–1318PubMedCrossRef Spinnato JA 2nd et al (2007) Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 110(6):1311–1318PubMedCrossRef
8.
Zurück zum Zitat Rumbold A et al (2008) Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 1:CD004227PubMed Rumbold A et al (2008) Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 1:CD004227PubMed
9.
Zurück zum Zitat Rodrigo R et al (2005) Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitamins. Pharmacol Ther 107(2):177–197PubMedCrossRef Rodrigo R et al (2005) Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitamins. Pharmacol Ther 107(2):177–197PubMedCrossRef
10.
Zurück zum Zitat Polyzos NP et al (2007) Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 62(3):202–206PubMedCrossRef Polyzos NP et al (2007) Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 62(3):202–206PubMedCrossRef
11.
Zurück zum Zitat Gilgun-Sherki Y et al (2002) Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54(2):271–284PubMedCrossRef Gilgun-Sherki Y et al (2002) Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54(2):271–284PubMedCrossRef
12.
Zurück zum Zitat Aris A et al (2008) Detrimental effects of high levels of antioxidant vitamins C and E on placental function: considerations for the vitamins in preeclampsia (VIP) trial. J Obstet Gynaecol Res 34(4):504–511PubMedCrossRef Aris A et al (2008) Detrimental effects of high levels of antioxidant vitamins C and E on placental function: considerations for the vitamins in preeclampsia (VIP) trial. J Obstet Gynaecol Res 34(4):504–511PubMedCrossRef
13.
Zurück zum Zitat Poston L et al (2006) Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367(9517):1145–1154PubMedCrossRef Poston L et al (2006) Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367(9517):1145–1154PubMedCrossRef
14.
Zurück zum Zitat Ohsawa I et al (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13(6):688–694PubMedCrossRef Ohsawa I et al (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13(6):688–694PubMedCrossRef
15.
Zurück zum Zitat Yang X et al (2011) Protective effects of hydrogen-rich saline in preeclampsia rat model. Placenta 32(9):681–686PubMedCrossRef Yang X et al (2011) Protective effects of hydrogen-rich saline in preeclampsia rat model. Placenta 32(9):681–686PubMedCrossRef
16.
Zurück zum Zitat Kharb S (2000) Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 93(1):37–39PubMedCrossRef Kharb S (2000) Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 93(1):37–39PubMedCrossRef
17.
Zurück zum Zitat Rumbold A et al (2005) Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 4:CD004227PubMed Rumbold A et al (2005) Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 4:CD004227PubMed
18.
Zurück zum Zitat Tao YX et al (1995) Human intermediate trophoblasts express chorionic gonadotropin/luteinizing hormone receptor gene. Biol Reprod 53(4):899–904PubMedCrossRef Tao YX et al (1995) Human intermediate trophoblasts express chorionic gonadotropin/luteinizing hormone receptor gene. Biol Reprod 53(4):899–904PubMedCrossRef
19.
Zurück zum Zitat Han SW, Lei ZM, Rao CV (1999) Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua. Mol Cell Endocrinol 147(1–2):7–16PubMedCrossRef Han SW, Lei ZM, Rao CV (1999) Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua. Mol Cell Endocrinol 147(1–2):7–16PubMedCrossRef
20.
Zurück zum Zitat Chaouat G et al (1995) Immuno-endocrine interactions in early pregnancy. Hum Reprod 10(Suppl 2):55–59PubMedCrossRef Chaouat G et al (1995) Immuno-endocrine interactions in early pregnancy. Hum Reprod 10(Suppl 2):55–59PubMedCrossRef
21.
Zurück zum Zitat Kharfi A et al (2005) Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies. Clin Biochem 38(8):717–721PubMedCrossRef Kharfi A et al (2005) Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies. Clin Biochem 38(8):717–721PubMedCrossRef
22.
Zurück zum Zitat Kharfi Aris A et al (2007) Dual action of H2O2 on placental hCG secretion: implications for oxidative stress in preeclampsia. Clin Biochem 40(1–2):94–97PubMedCrossRef Kharfi Aris A et al (2007) Dual action of H2O2 on placental hCG secretion: implications for oxidative stress in preeclampsia. Clin Biochem 40(1–2):94–97PubMedCrossRef
23.
Zurück zum Zitat Toth P et al (2001) Clinical importance of vascular LH/hCG receptors—a review. Reprod Biol 1(2):5–11PubMed Toth P et al (2001) Clinical importance of vascular LH/hCG receptors—a review. Reprod Biol 1(2):5–11PubMed
24.
Zurück zum Zitat Kharfi A et al (2003) Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 36(5):323–331PubMedCrossRef Kharfi A et al (2003) Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 36(5):323–331PubMedCrossRef
25.
Zurück zum Zitat Hunt JS, Chen HL, Miller L (1996) Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 54(3):554–562PubMedCrossRef Hunt JS, Chen HL, Miller L (1996) Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 54(3):554–562PubMedCrossRef
26.
Zurück zum Zitat Kharfi A et al (2006) Dissociation between increased apoptosis and expression of the tumor necrosis factor-alpha system in term placental villi with preeclampsia. Clin Biochem 39(6):646–651PubMedCrossRef Kharfi A et al (2006) Dissociation between increased apoptosis and expression of the tumor necrosis factor-alpha system in term placental villi with preeclampsia. Clin Biochem 39(6):646–651PubMedCrossRef
27.
Zurück zum Zitat Li Y et al (1992) Trophoblast-derived tumor necrosis factor-alpha induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor-dependent system in the normal human trophoblasts. J Clin Endocrinol Metab 74(1):184–191PubMed Li Y et al (1992) Trophoblast-derived tumor necrosis factor-alpha induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor-dependent system in the normal human trophoblasts. J Clin Endocrinol Metab 74(1):184–191PubMed
28.
Zurück zum Zitat Yui J et al (1994) Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 15(8):819–835PubMedCrossRef Yui J et al (1994) Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 15(8):819–835PubMedCrossRef
29.
Zurück zum Zitat Nakao A et al (2010) Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome—an open label pilot study. J Clin Biochem Nutr 46(2):140–149PubMedCentralPubMedCrossRef Nakao A et al (2010) Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome—an open label pilot study. J Clin Biochem Nutr 46(2):140–149PubMedCentralPubMedCrossRef
Metadaten
Titel
Effects of vitamin C, vitamin E, and molecular hydrogen on the placental function in trophoblast cells
verfasst von
Zhong Guan
Huai-fang Li
Li-li Guo
Xiang Yang
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3647-8

Weitere Artikel der Ausgabe 2/2015

Archives of Gynecology and Obstetrics 2/2015 Zur Ausgabe

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.